Classification and pharmacology of antiarrhythmic drugs.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Heart Journal

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MHJ.2000.106640PMID 10874257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management

  2001cited by this paper
• Electrophysiology and pharmacology of ibutilide.

  1996cited by this paper
• Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.

  1993cited by this paper
• Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

  1992cited by this paper
• Cardiac Electrophysiology of Adenosine: Basic and Clinical Concepts

  1991cited by this paper
• Goodman and Gilman's the pharmacologic basis of therapeutics

  1991cited by this paper
• The 'Sicilian Gambit' - A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms

  1991cited by this paper
• The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

  1991cited by this paper
• The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.

  1990cited by this paper
• Cardiac Electrophysiology: From Cell to Bedside

  1990cited by this paper
• Recurrence of ventricular tachycardia after conversion from proprietary to generic procainamide.

  1989cited by this paper
• Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.

  1989cited by this paper
• Antiarrhythmic agents: modulated receptor applications.

  1987cited by this paper
• Drug‐Device Interactions: Clinical Considerations

  1985cited by this paper
• Flecainide toxicity.

  1984cited by this paper
• Dynamic variability of binding of antiarrhythmic drugs during the evolution of acute myocardial infarction.

  1984cited by this paper
• A new method for constant plasma drug concentrations: application to lidocaine.

  1984cited by this paper
• Overview of physiology in senescence.

  1983cited by this paper
• Drug interactions with amiodarone

  1983cited by this paper
• Clinical pharmacology of propafenone.

  1983cited by this paper
• Oxidation phenotype--a major determinant of metoprolol metabolism and response.

  1982cited by this paper
• Digoxin disposition in obesity: clinical pharmacokinetic investigation.

  1981cited by this paper
• A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

  1980cited by this paper
• Role of concentration-dependent plasma protein binding in disopyramide disposition

  1979cited by this paper
• Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.

  1979cited by this paper
• Reduced beta-adrenoceptor sensitivity in the elderly.

  1979cited by this paper
• Reduced β‐adrenoceptor sensitivity in the elderly

  1979cited by this paper
• Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications.

  1979cited by this paper
• Classification of antiarrhythmic drugs

  1975cited by this paper
• Polymorphic acetylation of procainamide in man

  1975cited by this paper
• Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.

  1973cited by this paper
• Variation in biologic availability of digoxin from four preparations.

  1971cited by this paper

• Outcomes of extra-dose exposures of Vaughan Williams Class I or III antidysrhythmic medications

  2025cites this paper
• Critical role of extracellular loops in differential modulations of TTX-sensitive and TTX-resistant Nav channels

  2025cites this paper
• Perspective on Antiarrhythmic Drug Combinations.

  2023cites this paper
• Structural Basis for Pore Blockade of the Human Cardiac Sodium Channel Nav1.5 by the Antiarrhythmic Drug Quinidine.

  2021cites this paper
• Cardiovascular Management

  2020cites this paper
• Thérapeutique et problèmes généraux : antiarythmiques

  2019cites this paper
• Drugs and Antidotes in Acute Intoxication

  2019cites this paper
• Dose-dependent analgesic activity of mexiletine on thermally induced pain in rats

  2018cites this paper
• Failure of Intracardiac Pacing After Fatal Propafenone Overdose: A Case Report.

  2018cites this paper
• Discovery of a new mexiletine-derived agonist of the hERG K+ channel.

  2017cites this paper
• Drug Metabolism in Cardiovascular Disease

  2017cites this paper
• Role of abnormal repolarization in the mechanism of cardiac arrhythmia

  2017cites this paper
• Synthesis of six mexiletine derivatives with isoindolines attached as potential antioxidants and their evaluation as cardioprotective agents

  2015cites this paper
• Potentially inappropriate medication use in institutionalized older adults according to the Beers Criteria

  2014cites this paper
• Proposal for Warfarin Dosage Guideline during Warfarin-Propafenone Combination Therapy

  2013cites this paper
• Antiarythmiques

  2013cites this paper
• Overview of antiarrhythmic drug therapy for supraventricular tachycardia in children

  2013cites this paper
• Class I antiarrhythmic drugs produced a spinal anesthetic effect in rats.

  2011cites this paper
• Electrophysiologic, Pharmacokinetic, and Pharmacodynamic Values Indicating a Higher Risk of Torsades de Pointes

  2011cites this paper
• HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011.

  2011cites this paper
• Fibrillation atriale : de la physiopathologie aux traitements actuels

  2011cites this paper
• Proarrhythmia Induced by Propafenone: What is the Mechanism?

  2010cites this paper
• Design and Assessment of a Potent Sodium Channel Blocking Derivative of Mexiletine for Minimizing Experimental Neuropathic Pain in Several Rat Models

  2009influential citation
• Anti-Arrhythmic Drugs: Pharmacokinetics and Pharmacodynamics

  2009cites this paper
• Acute intoxication with propafenone and trimethoprim-sulfamethoxazole in a case of suicide attempt.

  2009cites this paper
• Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks.

  2008cites this paper
• Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT-Prolonging Drugs Associated with Torsades de Pointes

  2008cites this paper
• Bradyarrhythmias in pregnancy: a case report and review of management.

  2007cites this paper
• The Cutaneous Analgesic Effect of Class I Antiarrhythmic Drugs

  2007cites this paper
• Mexiletine has a local anesthetic effect on sciatic nerve blockade in rats

  2006cites this paper
• Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.

  2006cites this paper
• Stratégie d'utilisation des antiarythmiques en phase préhospitalière et aux urgences

  2005cites this paper
• Mise au point Stratégie d ’ utilisation des antiarythmiques en phase préhospitalière et aux urgences Emergency prehospital and inhospital management of antiarrhythmic agents

  2005cites this paper
• Resuscitation of the morbidly obese patient.

  2004cites this paper
• Bicarbonate therapy for unstable propafenone-induced wide complex tachycardia.

  2004cites this paper
• Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.

  2004cites this paper
• Amiodarone-Induced Skin Pigmentation and Pulmonary Fibrosis

  2002cites this paper
• Use of implantable cardioverter defibrillator and anti-arrhythmic agents in a parturient.

  2002cites this paper
• Antidysrhythmic agents at the turn of the twenty-first century: a current review.

  2002cites this paper
• Clinical Cardiac Electrophysiology Fellowship Teaching Objectives for the New Millennium

  2001cites this paper